A peptide extract taken from pineal gland tissue, developed in Vladimir Khavinson’s bioregulator programme and introduced into Soviet medical practice. Epitalon was later derived from it.

Is Epithalamin the same as Epitalon?

No. Epithalamin is the natural extract — a mixture of peptides. Epitalon is the synthesised four-amino-acid peptide (Ala-Glu-Asp-Gly) developed from that work. They are related but distinct compounds.

Why does the difference matter?

Because many findings attributed to Epitalon, particularly the long-running animal lifespan studies from 1979, were actually conducted with the extract. The lineage is genuine but the evidence does not automatically transfer from one compound to the other.

How strong is the evidence?

The animal lifespan work is substantial in volume but originates overwhelmingly from the institute that developed the compound, with limited independent replication. There is no approval from the TGA, FDA or EMA.

Research Library›Bioregulators & Neuropeptides›Epithalamin

Pineal Peptide Extract

Epithalamin: The Extract That Became Epitalon

Q: What is the difference between Epithalamin and Epitalon?

Epithalamin is an extract — a mixture of peptides drawn from pineal tissue. Epitalon is a single defined four-amino-acid molecule synthesised to a known sequence. The extract came first, and the synthetic compound was the attempt to isolate whatever in the mixture was active.

Q: Why does that distinction matter when reading the research?

Because most of the well-known long-term animal studies in this programme were conducted with the extract rather than the synthetic peptide. Evidence for one does not automatically transfer to the other, yet a considerable amount of writing about Epitalon cites work actually done with Epithalamin.

Before the four-amino-acid peptide, there was a pineal extract — and most of the famous long-term animal studies were done with this, not with what replaced it.

6 min read·4 studies cited·Updated July 2026

Evidence level

Registered as a medicine in Russia / CIS only

Used in Soviet and Russian clinical practice

What this level means

Quick Reference

Type	Peptide extract
Source tissue	Pineal gland
Synthetic successor	Epitalon (AEDG)
Notable for	The 1979 rat lifespan studies

What Is Epithalamin?

Epithalamin is a peptide extract taken from pineal gland tissue, and one of the six peptide preparations from the Khavinson programme introduced into Soviet medical practice. It is the compound Epitalon was derived from.

Why the distinction matters, in plain language: this is one of the most consequential naming confusions in the field. Many of the striking findings people attribute to Epitalon — particularly the long-running animal lifespan studies from 1979 onwards — were carried out with Epithalamin, the extract. Epitalon, the defined four-amino-acid peptide, came later. It is rather like crediting a modern espresso machine with the reputation earned by a century of stovetop pots. The lineage is genuine, the compounds are related, but they are not the same thing and the evidence does not transfer automatically.

What the Research Examines

The best-known work is the series of rodent lifespan studies beginning in 1979, reporting increased lifespan in rats given pineal peptide extract. Later studies from the institute examined effects on melatonin rhythm, immune markers and tumour incidence in ageing animals.

As a first-generation extract it is a mixture rather than a single molecule, with the same consequence as Thymalin or Cortexin — a stated purity figure cannot mean what it means for a synthesised peptide. The literature originates overwhelmingly from the developing institute and independent replication is limited.

The Extract That Came First

Epithalamin is easy to confuse with Epitalon, and the distinction matters more than the similar names suggest.

Epithalamin is an extract — a mixture of peptides pulled from pineal tissue. Epitalon is a single defined four-amino-acid molecule, synthesised to a known sequence. The extract came first; the synthetic compound was the attempt to identify and reproduce whatever in the mixture was doing the work.

Think of a herbal remedy and the drug later isolated from it. Willow bark preceded aspirin by a long way. The bark worked; nobody could say precisely what in it worked, or how much of it any given piece contained. Isolating the active molecule made it measurable, reproducible and verifiable — and meant the two can no longer be treated as the same thing.

This produces a specific problem worth naming. Most of the famous long-term animal studies in this programme were run with the extract, not the synthetic peptide. Evidence for one does not automatically carry to the other, and a great deal of writing about Epitalon quietly cites work done with Epithalamin. That distinction is covered in more depth in extracts vs synthetic peptides.

Frequently Asked Questions

Compiled by the Southern Pacific Labs research team. Last updated July 2026.

Browse the research range →

Published References

Khavinson VK, Malinin VV. “Gerontological Aspects of Genome Peptide Regulation.” Karger AG, Basel, 2005. Source
Anisimov VN, Khavinson VKh. “Peptide bioregulation of aging: results and prospects.” Biogerontology, 2010. PubMed
Khavinson VKh. “Peptides and Ageing.” Neuro endocrinology letters, 2002. PubMed
Khavinson VKh, Bondarev IE, Butyugov AA. “Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.” Bulletin of experimental biology and medicine, 2003. PubMed